Chugai Pharmaceutical Co Ltd
Chugai Pharmaceutical's GHG Emissions Data Preview
In 2024, Chugai Pharmaceutical completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).
Chugai Pharmaceutical has also provided a category-level breakdown for 10 out of 15 Scope 3 emissions categories, offering greater transparency into its value chain emissions.
| Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Scope 1 | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
Total Scope 2 | ||||
Market-Based | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
Location-Based | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
Total Scope 3 | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
Total Scope 1 Revenue Intensity (tCO2e/$M) | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
aVerified Sources Behind Chugai Pharmaceutical’s Greenhouse Gas (GHG) Emissions Data
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Chugai Pharmaceutical’s data sources below and access millions more through our Disclosure Search.
Insights into Chugai Pharmaceutical's Operational Emissions
In 2024, the total operational greenhouse gas (GHG) emissions of Chugai Pharmaceutical amounted to 116,838 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a
Compared to 2023, the total operational greenhouse gas (GHG) emissions of Chugai Pharmaceutical increased by 3.71%, suggesting that the company faced challenges in reducing its emissions from its core operations. a
Chugai Pharmaceutical's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are Chugai Pharmaceutical's Scope 1 emissions?
In 2024, the total Scope 1 emissions of Chugai Pharmaceutical were 51,143 metric tons of CO₂ equivalent (tCO₂e). a
Has Chugai Pharmaceutical reduced its Scope 1 emissions over time?
Since 2019, Chugai Pharmaceutical's Scope 1 emissions have increased by 6.35%, reflecting a rising long-term trend in Scope 1 emissions over time. a b
Compared to the previous year (2023), Chugai Pharmaceutical's Scope 1 emissions increased by 6.57%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations. a
What are Chugai Pharmaceutical's Scope 2 emissions?
In 2024, Chugai Pharmaceutical reported Scope 2 greenhouse gas (GHG) emissions of 3,267 tCO₂e using the market-based method and 65,695 tCO₂e using the location-based method. a
Has Chugai Pharmaceutical reduced its Scope 2 emissions over time?
Since 2019, Chugai Pharmaceutical's Scope 2 greenhouse gas (GHG) emissions ( Location-Based) have remained relatively stable, indicating that Chugai Pharmaceutical 's emissions have plateaued with no significant change in its energy consumption footprint. a b
Compared to the previous year (2023), Chugai Pharmaceutical's Scope 2 emissions (Location-Based) have remained relatively stable, indicating that Chugai Pharmaceutical 's emissions have plateaued with no significant change in its energy consumption footprint. a
What methodology does Chugai Pharmaceutical use for Scope 2 reporting?
In 2024, Chugai Pharmaceutical reported its Scope 2 emissions using the market-based method and using the location-based method. a
Chugai Pharmaceutical's Scope 2 Emissions Over Time
- Total Scope 2 Location-Based
- Total Scope 2 Market-Based
Insights into Chugai Pharmaceutical's Value Chain Emissions
In 2024, Chugai Pharmaceutical reported 981,329 metric tons of CO₂ equivalent (tCO₂e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain. a
The 2024 disclosure of Chugai Pharmaceutical includes a breakdown across 10 of the 15 Scope 3 categories defined by the GHG Protocol, matching the level of disclosure in 2023, demonstrating consistent Scope 3 emissions reporting coverage year over year. a
Chugai Pharmaceutical's Scope 3 Emissions Over Time
- Total Scope 3
- Year-over-Year Change
What are Chugai Pharmaceutical's Scope 3 emissions?
In 2024, Chugai Pharmaceutical reported total Scope 3 emissions of 981,329 metric tons of CO₂ equivalent (tCO₂e). a
Approximately 99.98% of these emissions originated from upstream activities such as purchased goods and capital goods, while 0.02% came from downstream activities like product use, distribution, and end-of-life treatment. a
Has Chugai Pharmaceutical reduced its Scope 3 emissions over time?
Since 2019, Chugai Pharmaceutical's Scope 3 emissions have remained relatively stable, indicating that Chugai Pharmaceutical 's emissions have plateaued with no significant change in its value chain footprint. a
Compared to the previous year (2023), Chugai Pharmaceutical's Scope 3 emissions decreased by 14.04%, highlighting the company's efforts to lower indirect emissions from its value chain. a
What categories of Scope 3 emissions does Chugai Pharmaceutical disclose?
In 2024, Chugai Pharmaceutical reported emissions for 10 out of the 15 Scope 3 categories defined by the GHG Protocol. a
This reflects a high level of granularity and transparency in the company's emissions reporting.
What are the main sources of Chugai Pharmaceutical's Scope 3 emissions?
In 2024, the largest contributors to Chugai Pharmaceutical's Scope 3 emissions were: a
- Purchased Goods and Services (Cat. 1): 684,778 tCO₂e (69.78%)
- Capital Goods (Cat. 2): 220,901 tCO₂e (22.51%)
- Downstream Transportation and Distribution (Cat. 9): 29,351 tCO₂e (2.99%)
Chugai Pharmaceutical's Scope 3 Emissions by Categories
Insights into Chugai Pharmaceutical’s GHG Emissions Intensity Compared to Industry Peers
In 2024, Chugai Pharmaceutical reported Scope 1 greenhouse gas (GHG) emissions of 51,143 tCO₂e and total revenues of USD 7,456 millions. This translates into an emissions intensity of 6.86 tCO₂e per millions USD. a
Chugai Pharmaceutical's Scope 1 Emissions Intensity Compared to Peers
How does Chugai Pharmaceutical's GHG emissions intensity compare to its peers?
In 2024, Chugai Pharmaceutical reported a Scope 1 emissions intensity of 6.86 tCO₂e per millions USD. Compared to the peer group median of 4.47 , this places the company above its industry benchmark, indicating it is less carbon-efficient than most competitors. a
Where does Chugai Pharmaceutical rank on GHG emissions intensity within its industry?
In 2024, Chugai Pharmaceutical ranked 17 out of 25 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a
Chugai Pharmaceutical is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency. a
Insights into Chugai Pharmaceutical's Total Carbon Footprint
In 2024, Chugai Pharmaceutical reported a total carbon footprint of 1,098,167 metric tons of CO₂ equivalent (tCO₂e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 12.44% decrease compared to 2023, indicating progress in reducing its overall greenhouse gas output. a
The largest contributor to Chugai Pharmaceutical's total carbon footprint was Scope 3 emissions, accounting for 89.36% of the company's total carbon footprint, followed by Scope 2 emissions at 5.98%. a